Brief: Adocia : Announces Initiation Of Comparative Study To Demonstrate Safety And Efficacy Of BC Lispro
30/07/2020 17:21
July 30 (Reuters) - ADOCIA SA ADOC.PA :
* INITIATES BIOCHAPERONE® LISPRO COMPARATIVE STUDY TO
VALIDATE
THDB INSULIN LISPRO FOR PHASE 3 BC LISPRO TRIALS IN EUROPE AND
U.S.
Source text for Eikon: ID:nNDL7PGtch
Further company coverage: ADOC.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Adocia SA
See all newsFrench biopharma firm Adocia H1 revenue drops on weaker feasibility study income
Brief: Adocia H1 Operating Income EUR -7.947 Million
Brief: Adocia Says Sanofi’S Exclusive Right For Partnership Agreement For Development Of M1Pram Has Expired
Brief: Adocia And Vester Finance Sign Shareholder Loan Agreement
Brief: Adocia Sees Challenges With GLP-1, Amylin & Other Metabolic Peptides